Live Breaking News & Updates on Iqvia

Stay informed with the latest breaking news from Iqvia on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Iqvia and stay connected to the pulse of your community

Marks Group Wealth Management Inc Buys 259 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Marks Group Wealth Management Inc raised its holdings in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 0.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 30,807 shares of the medical research company’s stock after buying an additional 259 shares during the quarter. […]

Contract-sales-medical-solutions , Sumitomo-mitsui-trust-holdings-inc , Marks-group-wealth-management-inc , Holdings-inc , Research-development-solutions , Securities-exchange-commission , Connor-clark-lunn-investment-management-ltd , Barclays , Technology-analytics-solutions , A-global-asset-management-inc , Eagle-asset-management-inc

Marks Group Wealth Management Inc Has $7.13 Million Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Marks Group Wealth Management Inc lifted its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 0.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,807 shares of the medical research company’s stock after acquiring an additional 259 shares during the […]

Robertw-baird , Leerink-partnrs , Contract-sales-medical-solutions , Marks-group-wealth-management-inc , Schwartz-investment-counsel-inc , Research-development-solutions , Securities-exchange-commission , Technology-analytics-solutions , Dfpg-investments , Exchange-commission , Sei-investments-co , Holdings-inc

Aspire Private Capital LLC Has $684,000 Position in IQVIA Holdings Inc. (NYSE:IQV)

Aspire Private Capital LLC increased its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 8.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,957 shares of the medical research company’s stock after buying an additional 235 […]

Leerink-partnrs , Wealth-management , Holdings-inc , Technology-analytics-solutions , Corefirst-bank , Contract-sales-medical-solutions , Exchange-commission , Family-office , Securities-exchange-commission , Advisornet-financial-inc , Research-development-solutions , Aspire-private-capital

Sumitomo Mitsui DS Asset Management Company Ltd Has $11.76 Million Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Sumitomo Mitsui DS Asset Management Company Ltd trimmed its holdings in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 11.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 50,806 shares of the medical research company’s stock after selling 6,667 shares during the period. […]

Leerink-partnrs , Carmel-capital-partners , Wetzel-investment-advisors-inc , Kornitzer-capital-management-inc , Holdings-inc , Exchange-commission , Barclays , Technology-analytics-solutions , Contract-sales-medical-solutions , Sumitomo-mitsui-ds-asset-management-company-ltd , Research-development-solutions , Sumitomo-mitsui

Sumitomo Mitsui DS Asset Management Company Ltd Sells 6,667 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Sumitomo Mitsui DS Asset Management Company Ltd lowered its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 11.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 50,806 shares of the medical research company’s stock after selling 6,667 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings […]

Leerink-partnrs , Research-development-solutions , Holdings-channel , Technology-analytics-solutions , Barclays , Sumitomo-mitsui-ds-asset-management-company-ltd , Contract-sales-medical-solutions , Holdings-inc , Norges-bank , Eagle-asset-management-inc , Sumitomo-mitsui , Management-company-ltd

Schwartz Investment Counsel Inc. Buys 7,050 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Schwartz Investment Counsel Inc. grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 4.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 178,690 shares of the medical research company’s stock after acquiring an additional 7,050 shares during the quarter. IQVIA comprises about 1.6% of Schwartz Investment Counsel Inc.’s investment […]

Kentucky , United-states , Massachusetts , Robertw-baird , Sei-investments-co , Securities-exchange-commission , Holdings-inc , Contract-sales-medical-solutions , Research-development-solutions , Technology-analytics-solutions , Schwartz-investment-counsel-inc

Brokerages Set IQVIA Holdings Inc. (NYSE:IQV) PT at $256.80

Shares of IQVIA Holdings Inc. (NYSE:IQV – Get Free Report) have been given an average rating of “Moderate Buy” by the fifteen brokerages that are presently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average […]

Robertw-baird , Leerink-partnrs , Jag-capital-management , Advisor-group , Technology-analytics-solutions , Laurel-wealth-advisors , Contract-sales-medical-solutions , Raleigh-capital-management-inc , Parkside-financial-bank , Holdings-inc , Research-development-solutions , Get-free-report

breast cancer: Gland Pharma gets USFDA nod for generic breast cancer drug

Gland Pharma has received approval from the USFDA to market a generic medication for breast cancer treatment, Eribulin Mesylate Injection. It's expected to be the first generic approval in the market, with sales of around USD 92 million in the US.

Drug-administration , Orbicular-pharmaceutical-technologies-pvt-ltd , Gland-pharma , Eribulin-mesylate-injection , Orbicular-pharmaceutical-technologies-pvt , Breast-cancer , Usfda , Us-food-and-drug-administration , Iqvia ,

DekaBank Deutsche Girozentrale Has $45.73 Million Stake in IQVIA Holdings Inc. (NYSE:IQV)

DekaBank Deutsche Girozentrale decreased its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 24.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 199,037 shares of the medical research company’s stock after selling 65,454 shares during […]

Dekabank-deutsche-girozentrale , Robertw-baird , Citigroup , Company-profile , Contract-sales-medical-solutions , Penserra-capital-management , B-riley-wealth-advisors-inc , Holdings-inc , Technology-analytics-solutions , Securities-exchange-commission , Parkside-financial-bank , Advisor-group

Addenda Capital Inc. Sells 344 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Addenda Capital Inc. lessened its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 0.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 44,346 shares of the medical research company’s stock after selling 344 shares during the period. Addenda […]

Exchange-commission , Prudential-plc , Holdings-inc , Contract-sales-medical-solutions , Parkside-financial-bank , Citigroup , Research-development-solutions , Addenda-capital-inc , Hightower-advisors , Technology-analytics-solutions , Covestor-ltd